Troponin I and Sepsis

Overview

Why Troponin Rises in Sepsis - Mechanisms

1. Cytokine-Mediated Myocardial Depression

• TNF-alpha and IL-6 directly impair cardiomyocyte function and promote apoptosis
• These inflammatory mediators increase nitric oxide (NO) production via inducible NOS (iNOS), causing myocardial calcium handling abnormalities
• IL-1beta and TNF-alpha suppress myosin heavy chain and impair actin-myosin cross-bridging, reducing contractility

2. Microvascular Dysfunction and Ischemia

• Sepsis causes widespread microvascular endothelial injury, platelet-fibrin microthrombi, and capillary plugging in the coronary microvasculature
• This impairs oxygen delivery to myocytes even without large-vessel obstruction
• The result is patchy subendocardial ischemia - a Type 2 myocardial infarction pattern (supply-demand mismatch)

3. Myocardial Cell Membrane Damage

• Bacterial toxins (particularly LPS from gram-negative organisms) and circulating cytokines increase myocyte membrane permeability
• This allows cytoplasmic troponin I to "leak" out without frank myocyte necrosis
• This distinguishes SRTE from the massive necrosis seen in Type 1 MI

4. Hemodynamic Stress

• Hypotension and reduced coronary perfusion pressure
• Tachycardia reduces diastolic filling time and increases oxygen demand
• These combine to create demand ischemia on a background of already impaired supply

5. Autonomic Nervous System Dysregulation

• Catecholamine surge causes direct myocardial toxicity (catecholamine-mediated injury)
• This is the same mechanism seen in Takotsubo syndrome, which must be differentiated from SRTE

Septic Cardiomyopathy

• Reversible biventricular dysfunction (normalizes in 7-10 days in survivors)
• Ventricular dilatation with reduced EF
• Diastolic dysfunction
• Global and regional wall hypokinesia
• Frequently accompanied by elevated troponin

Interpretation: Is It "False Positive"?

"Studies have supported the contention that the source of these levels is underlying noninfarction myocyte injury that occurs with these conditions."

Prognostic Significance

• Previous meta-analyses (Bessieres 2013, Sheyin 2015): Troponin elevation significantly associated with increased mortality
• 2025 meta-analysis (Critical Care, Gajardo et al.): Using high-sensitivity troponin assays and the current Sepsis-3 definition, the previously established association with short-term mortality was not confirmed - suggesting the prognostic weight may be less clear when using modern assays and definitions
• 2025 Korean multicenter cohort (JAHA, Choi et al., n=2141): Elevated troponin at sepsis recognition was not significantly associated with hospital mortality (35.2% vs 32.7%, OR 1.12, p=0.396) after propensity matching. However, landmark analysis showed lower survival after 1 week (log-rank p=0.033) and higher kidney SOFA scores through ICU day 7 (p=0.003), suggesting early adverse impact on organ dysfunction even if overall mortality signal is less clear
• A 2026 review in J Critical Care (Paraschiv et al.) concludes: natriuretic peptides (BNP/NT-proBNP) are more specific than troponins for diagnosing sepsis-induced cardiac dysfunction (SICD), and troponins alone are not sufficient to diagnose SICD - only to exclude AMI

Clinical Approach in the Septic Patient with Elevated Troponin I

1. Do not ignore it - it indicates genuine myocardial stress and is prognostically relevant
2. Do not automatically pursue coronary angiography - only ~10% have obstructive coronary disease; invasive workup without clinical/ECG indication causes harm
3. Seek clinical context: angina symptoms, new ECG changes (ST elevation, new LBBB), hemodynamic instability disproportionate to infection severity
4. Differentiate from Type 1 MI, Takotsubo, and myocarditis - all can occur in septic patients and alter management
5. Use serial troponin + echocardiography - repeat echo is the gold standard for diagnosing reversible septic cardiomyopathy; a pattern of new wall motion abnormalities in a distribution suggesting ACS warrants further evaluation
6. Combine with BNP/NT-proBNP - natriuretic peptides are significantly more elevated in patients who develop cardiac dysfunction in sepsis
7. In mild elevations (<2-3x ULN) in critically ill patients without clinical/ECG signs of ACS: no mandatory coronary workup required
8. Marked elevation (>5x ULN) in a patient not severely ill warrants more aggressive ACS workup

Summary